| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |